funfun

Bank of America's Lewis Goes Packing

Lewis's legacy?

Leaves behind a fraud-infested bank stained with serial scandals, and millions of alienated bank and brokerage customers, tens of thousands of sacked employees, and BAC shareholders whose investments have been dramatically debased.

Lewis also leaves with a massive personal fortune paid to him in return for undeniably shabby "leadership" performance!

...funfun..

Why Did Du Pont's Charles Holliday Join BofA's Board?

The "leaders" of BAC just don't get it. Milliions of Americans and investors are unarguably repulsed by the spectacle of massive bonuses paid to inept corporate and bank CEOs in return for mediocre performance or worse. DuPont Chairman Chad Holliday is a master of grabbing outsized bonuses for himself and his circa 100 bobble-heading DuPont Vice Presidents in return for sub-performances and destroying shareholder value. Is that the kind of "expertise" for which the bank is looking, given BAC is embroiled in a sordid scandal over executive bonuses? ...funfun..

Why Did Du Pont's Charles Holliday Join BofA's Board?

To think that DuPont's bumbling über boss, Chad Holliday can bring "credibility" to this fraud-infested bank with its serial scandals is laughable. In recent years, DuPont has pleaded guilty to criminal price-fixing in its global elastomers venture, been caught by the FDA illegally misrepresenting its medical products, deceitfully covered up its toxic Teflon chemical pollution and studies, been adjudged covertly contaminating an entire West Virginia town with toxic chemcals for decades and then LYING ABOUT IT, waged a war of "dirty tricks" bankrolling secret front organisations to smear and defame a superior-performing competitor, Monsanto, undsoweiter.
The Chairman of the disreputable DuPont adds nothing to BAC, in the opinion of the undersigned investor...funfun..

Cramer's Mad Money - Obama's First 100 Days (4/27/09)

DuPont's bounce-back since January is highly suspect because it appears some traders and investors are NOT factoring in--

(a) the yearly dividend of $1.64 is highly likely to be slashed in the midst of DuPont's cash flow famine and systemic weakness throughout, and more significantly,

(b) the unfolding BIG BLACK HOLE in Pharma earnings. Over $1 billion yearly in DuPont Pharma PTOI will soon disappear with the sure and certain expiration of two DuPont drug patents, Cozaar® and Hyzaar®. These patents and their exclusivity are the only assets left in DuPont's fading and phased-out Pharma "platform".

$1 billion-plus yearly in PTOI goes "POOF"! ...funfun..